These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 47887)

  • 1. Functional heterogeneity of lymphocytic choriomeningitis virus-specfic T lymphocytes. I. Identification of effector amd memory subsets.
    Johnson ED; Cole GA
    J Exp Med; 1975 Apr; 141(4):866-81. PubMed ID: 47887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection.
    Moskophidis D; Assmann-Wischer U; Simon MM; Lehmann-Grube F
    Eur J Immunol; 1987 Jul; 17(7):937-42. PubMed ID: 2886344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capacity of sensitized thymus-derived lymphocytes to induce fatal lymphocytic choriomeningitis is restricted by the H-2 gene complex.
    Doherty PC; Zinernagel RM
    J Immunol; 1975 Jan; 114(1 Pt 1):30-3. PubMed ID: 1078677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
    Byrne JA; Oldstone MB
    J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between LCM virus-specific secondary cytotoxic T lymphocytes generated by Con A and by the homologous antigen.
    Marker O; Andersen GT
    Immunology; 1979 Oct; 38(2):235-44. PubMed ID: 315920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus.
    Baenziger J; Hengartner H; Zinkernagel RM; Cole GA
    Eur J Immunol; 1986 Apr; 16(4):387-93. PubMed ID: 3084281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytic choriomeningitis virus-induced immunosuppression: a virus-induced macrophage defect.
    Jacobs RP; Cole GA
    J Immunol; 1976 Sep; 117(3):1004-9. PubMed ID: 956645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. I. Kinetics of induction in vitro and yields of effector cells.
    Dunlop MB; Blanden RV
    Immunology; 1976 Aug; 31(2):171-80. PubMed ID: 955675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine hepatitis caused by lymphocytic choriomeningitis virus. II. Cells involved in pathogenesis.
    Gossmann J; Lohler J; Utermohlen O; Lehmann-Grube F
    Lab Invest; 1995 May; 72(5):559-70. PubMed ID: 7745950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The timing of the immune response in relation to virus growth determines the outcome of the LCM infection.
    Thomsen AR; Volkert M; Marker O
    Acta Pathol Microbiol Scand C; 1979 Feb; 87C(1):47-54. PubMed ID: 433605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation between cytotoxic T lymphocytes and lethal murine lymphocytic choriomeningitis.
    Pfau CJ; Saron MF; Pevear DC
    J Immunol; 1985 Jul; 135(1):597-602. PubMed ID: 3873496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency and effectiveness of cloned virus-specific cytotoxic T lymphocytes in vivo.
    Klavinskis LS; Tishon A; Oldstone MB
    J Immunol; 1989 Sep; 143(6):2013-6. PubMed ID: 2476492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope.
    Gegin C; Lehmann-Grube F
    J Immunol; 1992 Nov; 149(10):3331-8. PubMed ID: 1385522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice.
    Lehmann-Grube F; Assmann U; Löliger C; Moskophidis D; Löhler J
    J Immunol; 1985 Jan; 134(1):608-15. PubMed ID: 3871115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological tolerance to lymphocytic choriomeningitis virus in neonatally infected virus carrier mice: evidence supporting a clonal inactivation mechanism.
    Cihak J; Lehmann-Grube F
    Immunology; 1978 Feb; 34(2):265-75. PubMed ID: 304840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D.
    Zinkernagel RM; Welsh RM
    J Immunol; 1976 Nov; 117(5 Pt 1):1495-502. PubMed ID: 794412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination.
    Wille A; Gessner A; Lother H; Lehmann-Grube F
    Eur J Immunol; 1989 Jul; 19(7):1283-8. PubMed ID: 2503388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune response of the mouse to lymphocytic choriomeningitis virus. IV. Enumeration of antibody-producing cells in spleens during acute and persistent infection.
    Moskophidis D; Lehmann-Grube F
    J Immunol; 1984 Dec; 133(6):3366-70. PubMed ID: 6092472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral immune responses of fully allogeneic irradiation bone marrow mouse chimeras.
    Fang LB; Gessner A; Kühlcke K; Gossmann J; Lehmann-Grube F
    J Immunol; 1991 Nov; 147(9):3133-8. PubMed ID: 1919008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.